VIJAYA Vijaya Diagnostic Centre Q4 FY25 results (Jan–Mar 2025) and concall
Vijaya Diagnostic Centre Limited reported a strong Q4 FY25 with consolidated revenue of INR 173 crores, growing 12% YoY, and a healthy EBITDA margin of 39.8%. Full-year FY25 revenue grew 24% to INR 681 crores. The company successfully launched 6 new hubs and plans for further expansion, with a new CTO to drive digital initiatives. While gross margins saw some contraction due to wellness and input costs, and a temporary EBITDA drag is expected from new hubs, management remains confident in achieving 15%+ CAGR over the next 2-3 years.
You’re reading a preview. Opening the full call uses 1 concall credit.
Sign in to use your monthly call allowance.
What they filed
| Line item | Q2 FY25 | Q3 FY25 | Q4 FY25 |
|---|---|---|---|
| Revenue | 183 | 169 | 173 |
| EBITDA | 76 | 67 | 69 |
| Net profit | 42 | 35 | 35 |
How to read this
₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.
Inve summary of a publicly available earnings call transcript; see how call summaries are prepared. Not investment advice.
